Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Cybersecurity Stocks CRWD, PLTR, FTNT Pop Higher on Russia-Ukraine Fears

By Chris MacDonald, InvestorPlace Contributor

Today's outright invasion of Ukraine by Russia has sent cybersecurity stocks soaring as investors look for safe places to put their money.

SBRCY Stock Alert: What Is the Sberbank of Russia and Why Are Shares Plunging Today?

By Chris MacDonald, InvestorPlace Contributor

Today, the Russian invasion of Ukraine has led to plummeting stock prices for Russian banks including Sberbank and SBRCY stock.

ASAN, TSLA, NOW, AAPL: Why Are Stocks Down Today?

By Chris MacDonald, InvestorPlace Contributor

From Apple to Tesla, investors may be wondering why are some stocks down today when others are rising. Let's dive into this.

Is DKNG Stock a Buy on Doubled Revenue? 3 Analysts Weigh In on DraftKings Price Predictions

By Chris MacDonald, InvestorPlace Contributor

Here's where the experts think DKNG stock could be headed from here after the company recently reported difficult-to-assess earnings.

Is CLOV Stock a Buy at 52-Week Lows? 3 Analysts Weigh In on Clover Health.

By Chris MacDonald, InvestorPlace Contributor

Here's what some expert analysts think about Clover Health and CLOV stock amid the stock's impressive decline to new 52-week lows.

KOD Stock Alert: Why Is Kodiak Sciences Plunging 80% Today?

By Chris MacDonald, InvestorPlace Contributor

Disappointing drug trial results have sent Kodiak Sciences and shares of KOD stock plunging more than 80% in today's trading session.

Is WISH Stock a Buy Right Now? 4 Analysts Weigh In on ContextLogic Price Predictions.

By Chris MacDonald, InvestorPlace Contributor

Some interesting takes are starting to materialize around ContextLogic and WISH stock, as this company sees continued selling pressure today.

HMHC Stock Alert: The Veritas Capital News Lifting Houghton Mifflin Harcourt Today

By Chris MacDonald, InvestorPlace Contributor

Today, a massive $2.8 billion acquisition of Houghton Mifflin by Veritas has sent shares of HMHC stock soaring more than 15%.

PTON Stock Runs Into the Spotlight Thanks to Unexplained Peloton Outage

By Chris MacDonald, InvestorPlace Contributor

For investors in Peloton and PTON stock, today's price action provides continued downside pressure, as the company experiences an outage.

INDO Stock Alert: 5 Things to Know About Red-Hot Indonesia Energy

By Chris MacDonald, InvestorPlace Contributor

Today, one of the best-performing companies in an otherwise red market is Indonesia Energy, which has seen INDO stock surge 80% today.

Load More